Anqi Xu

786 total citations
47 papers, 548 citations indexed

About

Anqi Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anqi Xu has authored 47 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anqi Xu's work include RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Anqi Xu is often cited by papers focused on RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Anqi Xu collaborates with scholars based in China, United States and Hong Kong. Anqi Xu's co-authors include Navindra P. Seeram, David Heber, Yue Niu, Kan Gao, Susan Henning, Ye Song, Shelley Pallan, Mi Kyoung Park, Gary Sweeney and Mika Eguchi and has published in prestigious journals such as Bioinformatics, Stroke and Journal of Nutrition.

In The Last Decade

Anqi Xu

40 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anqi Xu China 13 257 103 88 69 52 47 548
Atul Rawat India 16 341 1.3× 105 1.0× 93 1.1× 71 1.0× 40 0.8× 33 767
Nashrah Ahmad United States 7 332 1.3× 100 1.0× 51 0.6× 72 1.0× 42 0.8× 12 874
Ziping Jiang China 17 364 1.4× 126 1.2× 79 0.9× 62 0.9× 24 0.5× 40 733
Pelin Telkoparan‐Akillilar Türkiye 13 440 1.7× 94 0.9× 78 0.9× 35 0.5× 34 0.7× 30 686
Yuetao Zhou China 15 310 1.2× 63 0.6× 78 0.9× 63 0.9× 27 0.5× 33 630
Yu Tao China 19 376 1.5× 117 1.1× 94 1.1× 97 1.4× 28 0.5× 28 786
Yuko Nagayasu Japan 18 449 1.7× 98 1.0× 54 0.6× 68 1.0× 26 0.5× 32 718
Mo‐Li Zhu China 16 207 0.8× 111 1.1× 45 0.5× 86 1.2× 25 0.5× 34 561

Countries citing papers authored by Anqi Xu

Since Specialization
Citations

This map shows the geographic impact of Anqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Xu more than expected).

Fields of papers citing papers by Anqi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Xu. The network helps show where Anqi Xu may publish in the future.

Co-authorship network of co-authors of Anqi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Xu. A scholar is included among the top collaborators of Anqi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Xu. Anqi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Xin, Chi Huang, Anqi Xu, et al.. (2025). Association between triglyceride-glucose index and intracranial aneurysm rupture: findings from a retrospective study. Neurosurgical Review. 48(1). 521–521. 1 indexed citations
2.
Wang, Yazhen, Anqi Xu, Kang Tang, et al.. (2025). Mechanistic insights into IL-6-mediated NK cell dysfunction in NSCLC via the IRE1α-XBP1s-STAT3-UBE2S axis. npj Precision Oncology. 9(1). 361–361.
3.
6.
Nie, Di, Duo Gao, Anqi Xu, et al.. (2024). Enhanced cytosolic RNA delivery through early endosome fusion-mediated release via probiotic-derived lipopolysaccharide (LPS)-incorporated vesicles. Nano Today. 59. 102480–102480. 2 indexed citations
7.
Li, Shanshan, Yixuan Wang, Anqi Xu, et al.. (2024). Dietary selenomethionine reduced oxidative stress by resisting METTL3-mediated m6A methylation level of Nrf2 to ameliorate LPS-induced liver necroptosis in laying hens. The Journal of Nutritional Biochemistry. 125. 109563–109563. 11 indexed citations
8.
Xu, Anqi, Yixuan Wang, Dongliu Luo, et al.. (2024). By regulating the IP3R/GRP75/VDAC1 complex to restore mitochondrial dynamic balance, selenomethionine reduces lipopolysaccharide‐induced neuronal apoptosis. Journal of Cellular Physiology. 239(4). e31190–e31190. 5 indexed citations
9.
Zhang, Hao, Anqi Xu, Xiangxiang Li, Binbin Pan, & Xin Wan. (2024). Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study. ImmunoTargets and Therapy. Volume 13. 205–214.
10.
Wang, Jun, Anqi Xu, Daoqiang Lu, et al.. (2023). In situ formed tissue-adhesive carboxymethyl chitosan hydrogels through photoclick chemistry for wound healing. European Polymer Journal. 203. 112680–112680. 10 indexed citations
11.
Feng, Xin, Xin Tong, Chao Peng, et al.. (2023). A Mendelian randomisation, propensity score matching study to investigate causal association between serum homocysteine and intracranial aneurysm. Stroke and Vascular Neurology. 9(3). 202–211. 4 indexed citations
12.
Xu, Anqi, Nan Zhang, Shixing Su, et al.. (2023). A highly stretchable, adhesive, and antibacterial hydrogel with chitosan and tobramycin as dynamic cross-linkers for treating the infected diabetic wound. Carbohydrate Polymers. 324. 121543–121543. 23 indexed citations
13.
Chen, Shasha, Tong Xu, Anqi Xu, et al.. (2023). Quercetin alleviates zearalenone-induced apoptosis and necroptosis of porcine renal epithelial cells by inhibiting CaSR/CaMKII signaling pathway. Food and Chemical Toxicology. 182. 114184–114184. 11 indexed citations
14.
Xu, Anqi, Wenxing Li, Kexin Wang, et al.. (2023). Screening of key functional components of Taohong Siwu Decoction on ischemic stroke treatment based on multiobjective optimization approach and experimental validation. BMC Complementary Medicine and Therapies. 23(1). 178–178. 4 indexed citations
15.
Xu, Anqi, et al.. (2023). Research progress of Claudin-low breast cancer. Frontiers in Oncology. 13. 1226118–1226118. 13 indexed citations
16.
Zhang, Zilong, et al.. (2022). webSCST: an interactive web application for single-cell RNA-sequencing data and spatial transcriptomic data integration. Bioinformatics. 38(13). 3488–3489. 27 indexed citations
17.
Zeng, Yu, Tianshi Que, Jie Lin, et al.. (2021). Oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma. Molecular Therapy — Nucleic Acids. 23. 769–782. 18 indexed citations
18.
Wu, Zhiyong, Jie Luo, Anqi Xu, et al.. (2020). MiR-4310 induced by SP1 targets PTEN to promote glioma progression. Cancer Cell International. 20(1). 567–567. 12 indexed citations
19.
Lin, Jie, Zhiyong Wu, Jie Luo, et al.. (2020). MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop. Cell Death and Disease. 11(4). 269–269. 18 indexed citations
20.
Chen, Xihang, Yunfan He, Anqi Xu, et al.. (2019). Increase of glandular epithelial cell clusters by an external volume expansion device promotes adipose tissue regeneration by recruiting macrophages. Bioscience Reports. 39(2). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026